newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Tetra strengthens its intellectual property position with PCT and provisional patent applications for its innovative therapeutic, ARDS-003. MONTREAL, Nov. 29, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or